Pain Phenotypes in Patients With Fibromyalgia Syndrome
CompletedNCT05941780
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Fibromyalgia Syndrome (FMS); is a complex syndrome characterized by many symptoms such as chronic widespread pain, fatigue and sleep disorders, cognitive dysfunctions and psychiatric disorders. It has been stated that there is an urgent need for studies examining the clinicimetric and psychometric properties of the pain phenotype criteria in terms of patients receiving the most appropriate treatment, clinicians deciding on the appropriate treatment, and contributing to the research of scientists. Despite all this, no study has yet been found that describes the pain phenotypes in fibromyalgia syndrome and how different types of pain affect patients. The primary aim of this study is to determine the chronic pain phenotypes in individuals with FMS. The secondary aim of this study to determine the inter-rater and intra-rater reliability of the algorithm used in the determination of pain phenotypes and to assessment the clinical effects of different pain phenotypes on individuals with FMS in terms of pain severity, disease severity, quality of life and catastrophe.
Study details
- Official title
- Pain Phenotypes in Patients With Fibromyalgia Syndrome
- Conditions
- Interventions
- Diagnostic test: Pain classification method
- Sponsor
- Kutahya Health Sciences University
- Start date
- 2023-07-10
- Primary completion
- 2023-11-28
- Sex
- Female
- Age range
- from 18 Years to 60 Years
- Results posted
- No results posted in this snapshot
- Countries
- Turkey (Türkiye)
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * being diagnosed with fibromyalgia syndrome according to the criteria of the American Rheumatology Association , * not receiving active treatment related to physiotherapy, * volunteering to participate in the study Exclusion Criteria: * diagnosed endocrine, neuromuscular, infectious and inflammatory diseases, * severe mental and psychological disorders, using psychological drugs (SSRIs and SNRIs) * illiterate * problems with hearing and vision
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT05941780